Trexquant Investment’s BioTelemetry, Inc. BEAT Stock Holding History

Trexquant Investment’s Portfolio BEAT Stock Details BEAT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-5,405	Closed	-$323K	–	1482
2018 Q4	$323K	Buy	+5,405	New	+$325K	0.02%	758
2018 Q2	–	Sell	-15,736	Closed	-$489K	–	1432
2018 Q1	$489K	Buy	+15,736	New	+$517K	0.03%	641
2017 Q2	–	Sell	-10,772	Closed	-$312K	–	1414
2017 Q1	$312K	Buy	+10,772	New	+$267K	0.04%	741
2016 Q4	–	Sell	-17,397	Closed	-$323K	–	1270
2016 Q3	$323K	Buy	17,397 +2,057	+13%	+$38.8K	0.07%	447
2016 Q2	$250K	Sell	15,340 -20,555	-57%	-$302K	0.03%	719
2016 Q1	$419K	Sell	35,895 -9,968	-22%	-$111K	0.05%	619
2015 Q4	$536K	Sell	45,863 -7,086	-13%	-$89.7K	0.05%	653
2015 Q3	$648K	Buy	+52,949	New	+$675K	0.06%	624

Other funds holding BEAT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

HRCM

Hood River Capital Management Palm Beach Gardens, Florida $9.98B AUM 145.42% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Trexquant Investment's BEAT Position: Q1 2019 in Review

Trexquant Investment sold out of BioTelemetry, Inc. (BEAT) in Q1 2019, closing a stake of 5,405 shares — an estimated $323K sold.

Trexquant Investment first reported a position in BEAT in Q3 2015 and held it in 8 quarters. The position peaked at $648K in Q3 2015. 311 funds tracked by Wall St. Rank hold BEAT as of Q1 2019.

Trexquant Investment reported no remaining BioTelemetry, Inc. position as of Q1 2019 after selling out during the quarter.
Trexquant Investment sold 5,405 BioTelemetry, Inc. shares in Q1 2019, an estimated $323K.
Trexquant Investment first reported a position in BioTelemetry, Inc. in Q3 2015 and held it in 8 quarters.
Trexquant Investment's BioTelemetry, Inc. position peaked at $648K in Q3 2015.
311 funds tracked by Wall St. Rank held BioTelemetry, Inc. as of Q1 2019.

Based on Trexquant Investment's 13F filing for Q1 2019, filed 13 May 2019.